MiRNA Sequencing & Assay Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global MiRNA Sequencing and Assay Market is segmented by Product (Sequencing Consumables and Library Preparation Kits), Technology (Sequencing by Synthesis, Ion Semiconductor, SOLiD, and Nanopore Sequencing), End-User (Clinical Laboratory, Life Science Organization, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

MiRNA Sequencing & Assay Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

MiRNA Sequencing and Assay Industry Overview

The miRNA sequencing and assay market is moderately competitive and consists of several key players. Currently, a few major players are dominating the market in terms of market share, while others are actively making acquisitions and launching new products to strengthen their market positions globally. Among the leading companies in the market are Illumina, Inc., Thermo Fisher Scientific, Qiagen N.V., Perkinelmer, Inc., and Takara Bio, Inc. These companies have a strong presence in the market and offer a wide range of miRNA sequencing and assay products to meet the needs of their customers.

MiRNA Sequencing and Assay Market Leaders

  1. Illumina, Inc.

  2. Thermo Fisher Scientific

  3. Qiagen N.V.

  4. Perkinelmer, Inc.

  5. Takara Bio, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Global MiRNA Sequencing And Assay Market Concentration